Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | GS-4528 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on GS-4528 (Jun 2023). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| GS-4528 | GS 4528|GS4528 | Limited information is currently available on GS-4528 (Jun 2023). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT05840224 | Phase I | GS-4528 + Zimberelimab GS-4528 | Study of GS-4528 in Adults With Solid Tumors | Active, not recruiting | USA | GBR | ESP | CAN | 2 |